Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allendorf DJ, Ostroff G, Baran JT, Dyke CW, Ratajczak MZ, Ross GD. (2003) Oral WGP β glucan treatment accelerates myeloid recovery and survival after radiation exposure. In: Unified Science & Technology for Reducing Biological Threats & Countering Terrorism, p. 104–113.
Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, Hackett NR, Crystal RG, Witte L, Hicklin DJ, Bohlen P, Eaton D, Lyden D, de Sauvage F, Rafii S. (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med.;10:64-71.
Bunting S, Widmer R, Lipari T, Rangell L, Steinmetz H, Carver-Moore K, Moore MW, Keller GA, de Sauvage FJ. (1997) Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood;90:3423-9.
Burstein SA, Mei RL, Henthorn J, Friese P, Turner K. (1992) Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J Cell Physiol. 153:305-12.
Christenson JT. (1999) Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg.;15:394-349.
Coombe D.R., Watt S.M., Parish C.R (1994) Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate, Blood 84; 739–752.
Crass T, Raffetseder U, Martin U, Grove M, Klos A, Kohl J, Bautsch W. (1996) Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells, Eur J Immunol 26; 1944–1950
Gainsford T, Nandurkar H, Metcalf D, Robb L, Begley CG, Alexander WS. (2000) The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Blood; 95:528-34.
Gewirtz AM. (1995) Megakaryopoiesis: state of the art. Thromb Haemost.74:204-209.
Goldfarb RD, Parrillo JE. (2005) Complement. Crit Care Med.; 33:482-484.
Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. (1994) Thrombocytopenia in c-mpl-deficient mice. Science. 265:1445-1447.
Gurney AL, de Sauvage FJ. (1996) Dissection of c-Mpl and thrombopoietin function: studies of knockout mice and receptor signal transduction. Stem Cells.14 Suppl 1:116-23.
Hamada T, Mohle R, Hesselgesser J, Hoxie J, Nachman RL, Moore MA, Rafii S. (1998) Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med.;188:539-48.
Hodohara K, Fujii N, Yamamoto N, Kaushansky K. (2000) Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood;95:769-75.
Kowalska MA, Ratajczak J, Hoxie J, Brass LF, Gewirtz A, Poncz M, Ratajczak MZ. (1999) Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets. Br J Haematol.;104:220-229.
Lane WJ, Dias S, Hattori K, Heissig B, Choy M, Rabbany SY, Wood J, Moore MA, Rafii S. (2000) Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood.;96:4152-9.
Long MW, Hoffman R. (1999) Hematology: basic principles and practice. Eds. Churchill Livingstone. 245
Majka M, Ratajczak J, Villaire G, Kubiczek K, Marquez LA, Janowska-Wieczorek A, Ratajczak MZ. (2002) Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Exp Hematol.;30:751-60
Majka M, Janowska-Wieczorek A, Ratajczak J, Kowalska MA, Vilaire G, Pan ZK, Honczarenko M, Marquez LA, Poncz M, Ratajczak MZ. (2000) Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood.;96:4142-51.
Neben TY, Loebelenz J, Hayes L, McCarthy K, Stoudemire J, Schaub R, Goldman SJ. (1993) Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood.;81:901-908.
Nguyen DH, Taub D. (2002) CXCR4 function requires membrane cholesterol: implications for HIV infection. J Immunol.;168:4121-6.
Ratajczak MZ, Reca R, Wysoczynski M, Kucia M, Baran JT, Allendorf DJ, Ratajczak J, Ross GD. (2004) Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia.;18:1482-90.
Ratajczak J, Reca R, Kucia M, Majka M, Allendorf DJ, Baran JT, Janowska-Wieczorek A, Wetsel RA, Ross GD, Ratajczak MZ. (2004) Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood 103:2071-8.
Ratajczak M.Z., Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J (2006) The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorogenesis. Leukemia 20:1915-24.
Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, Franchini S, Glodek A, Honczarenko M, Spruce LA, Janowska-Wieczorek A, Lambris JD, Ratajczak MZ. (2003) Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood.;101:3784-93.
Riviere C, Subra F, Cohen-Solal K, Cordette-Lagarde V, Letestu R, Auclair C, Vainchenker W, Louache F. (1999) Phenotypic and functional evidence for the expression of CXCR4 receptor during megakaryocytopoiesis. Blood.;93:1511-23.
Sasaki H, Hirabayashic Y, Ishibashid T, Inoueb T, Matsudaa M, Kaia S, Ikutaa S, Yokoyamad K, Yokotac T, Maruyamad Y and Matsuyamaa S. (1995) Effects of erythropoietin, IL-3, IL-6 and LIF on a murine megakaryoblastic cell line: growth enhancement and expression of receptor mRNAs. Leuk Res.;19:95-102
Schafer AI. (2001) Thrombocytosis and thrombocythemia. Blood Rev.;15:159-66.
Teixido J., Hemler M.E., Greenberger J.S, Anklesaria P. (1992) Role of β 1 and β 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma, J Clin Invest 90:358–367.
Tornetta M.A., Foley J.J., Sarau H.M., Ames R.S. (1997) The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression, J Immunol 158: 5277–5282.
Volanakis J.E., Frank M.M. (1998) The human complement system in health and disease, NetLibrary Inc., New York
Walport M.J. (2001) Complement. First of two parts, N Engl J Med 344:1058–1066.
Walport M.J. (2001) Complement. Second of two parts, N Engl J Med 344:1140–1144.
Wang JF, Liu ZY, Groopman JE. (1998) The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood.;92:756-64
Wysoczynski M, Reca R, Ratajczak J, Kucia M, Shirvaikar N, Honczarenko M, Mills M, Wanzeck J, Janowska-Wieczorek A, Ratajczak MZ. (2005) Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 105:40-8.
Wysoczynski M, Kucia M, Ratajczak J, Ratajczak M.Z. (2007) Cleavage fragments of third complement component (C3) enhance SDF-1 mediated platelet production during reactive thrombocytosis. Leukemia 21:(in press).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this paper
Cite this paper
Wysoczynski, M., Ratajczak, J., Reca, R., Kucia, M., Ratajczak, M.Z. (2007). The Third Complement Component as Modulator of Platelet Production. In: Lambris, J.D. (eds) Current Topics in Innate Immunity. Advances in Experimental Medicine and Biology, vol 598. Springer, New York, NY. https://doi.org/10.1007/978-0-387-71767-8_16
Download citation
DOI: https://doi.org/10.1007/978-0-387-71767-8_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-71765-4
Online ISBN: 978-0-387-71767-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)